GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Balance Sheet Cash And Cash Equivalents

Acticor Biotech (XPAR:ALACT) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Acticor Biotech (XPAR:ALACT) Business Description

Industry
Traded in Other Exchanges
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.